Boehringer Ingelheim Pharma Gmbh And Co ... vs The Controller Of Patents & Anr on 24 February, 2026
with a priority date of 21 August 2002, for the
pharmaceutical product Linagliptin. On 17 February 2022, CO
(COMM. IPD-PAT) 38/20226 was filed